HOW SARCLISA WORKS
SARCLISA: A targeted immunotherapy
Designed to find and bind
SARCLISA is not chemotherapy. It is a kind of treatment called a monoclonal antibody — a type of immunotherapy — that works with your body's immune system.
SARCLISA is able to "find and bind" to myeloma cells and helps to stop the spread of multiple myeloma.
SARCLISA works to control the spread of multiple myeloma in 3 ways
SARCLISA finds and binds to myeloma cells and exposes
them for elimination by your immune system.
SARCLISA helps boost your immune system, making it harder for myeloma cells to survive.
SARCLISA directly kills myeloma cells.
-
SARCLISA 
Immune system cell
Myeloma cell
SARCLISA works to control the spread of multiple myeloma in 3 ways
- SARCLISA
- Immune system cell
- Myeloma cell
SARCLISA finds and binds to myeloma cells and exposes
them for elimination by your immune system.
SARCLISA helps boost your immune system, making it harder for myeloma cells to survive.
SARCLISA directly kills myeloma cells.
SARCLISA is not chemotherapy. SARCLISA is a targeted immunotherapy.
Watch the story of how SARCLISA works to fight Multiple Myeloma
Find out more about how SARCLISA was studied and see the results of the SARCLISA Phase 3 study.
CareASSIST helps eligible patients with access and support for SARCLISA.